The store will not work correctly when cookies are disabled.
(E)-3-(4-(dimethylamino)phenyl)-1-(5-isobutylpyrazin-2-yl)prop-2-en-1-one
ID: ALA2288602
PubChem CID: 6474721
Max Phase: Preclinical
Molecular Formula: C19H23N3O
Molecular Weight: 309.41
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)Cc1cnc(C(=O)/C=C/c2ccc(N(C)C)cc2)cn1
Standard InChI: InChI=1S/C19H23N3O/c1-14(2)11-16-12-21-18(13-20-16)19(23)10-7-15-5-8-17(9-6-15)22(3)4/h5-10,12-14H,11H2,1-4H3/b10-7+
Standard InChI Key: IADGKFOBGSWQBI-JXMROGBWSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
19.0788 -15.3367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0776 -16.1563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7857 -16.5652 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.4953 -16.1558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4925 -15.3331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7839 -14.9279 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.1987 -14.9219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9079 -15.3278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1956 -14.1047 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.6141 -14.9166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3233 -15.3225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3233 -16.1385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0317 -16.5444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7388 -16.1331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7331 -15.3117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0241 -14.9095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3696 -16.5643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3689 -17.3815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6609 -17.7895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0763 -17.7907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4486 -16.5381 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.4528 -17.3552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1542 -16.1259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
7 9 2 0
8 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
2 17 1 0
17 18 1 0
18 19 1 0
18 20 1 0
14 21 1 0
21 22 1 0
21 23 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 309.41 | Molecular Weight (Monoisotopic): 309.1841 | AlogP: 3.64 | #Rotatable Bonds: 6 |
Polar Surface Area: 46.09 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.73 | CX LogP: 3.51 | CX LogD: 3.51 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.60 | Np Likeness Score: -0.62 |
References
1. Opletalová V, Hartl J, Patel A, Palát K, Buchta V.. (2002) Ring substituted 3-phenyl-1-(2-pyrazinyl)-2-propen-1-ones as potential photosynthesis-inhibiting, antifungal and antimycobacterial agents., 57 (2): [PMID:11902656] [10.1016/s0014-827x(01)01187-9] |